ORIGINAL ARTICLE
Apoptosis initiation and angiogenesis inhibition: melanoma targets for nanosecond pulsed electric fields
Article first published online: 2 APR 2010
DOI: 10.1111/j.1755-148X.2010.00704.x
© 2010 John Wiley & Sons A/S
Additional Information
How to Cite
Chen, X., Kolb, J. F., Swanson, R. J., Schoenbach, K. H. and Beebe, S. J. (2010), Apoptosis initiation and angiogenesis inhibition: melanoma targets for nanosecond pulsed electric fields. Pigment Cell & Melanoma Research, 23: 554–563. doi: 10.1111/j.1755-148X.2010.00704.x
Publication History
- Issue published online: 16 JUL 2010
- Article first published online: 2 APR 2010
- PUBLICATION DATA Received 3 February 2010, revised and accepted for publication 30 March 2010, published online 2 April 2010
- Abstract
- Article
- References
- Cited By
Keywords:
- electric fields;
- non-thermal effects;
- apoptosis;
- angiogenesis;
- caspases;
- DNA damage;
- DNA double strand breaks
Summary
Many effective anti-cancer strategies target apoptosis and angiogenesis mechanisms. Applications of non-ionizing, nanosecond pulsed electric fields (nsPEFs) induce apoptosis in vitro and eliminate cancer in vivo; however in vivo mechanisms require closer analysis. These studies investigate nsPEF-induced apoptosis and anti-angiogenesis examined by fluorescent microscopy, immunoblots, and morphology. Six hours after treatment with one hundred 300 ns pulses at 40 kV/cm, cells transiently expressed active caspases indicating that caspase-mediated mechanisms. Three hours after treatment transient peaks in Histone 2AX phosphorylation coincided with terminal deoxynucleotidyl transferase dUTP nick end labeling positive cells and pyknotic nuclei, suggesting caspase-independent mechanisms on nuclei/DNA. Large DNA fragments, but not 180 bp fragmentation ladders, were observed, suggesting incomplete apoptosis. Nevertheless, tumor weight and volume decreased and tumors disappeared. One week after treatment, vessel numbers, vascular endothelial growth factor (VEGF), platelet derived endothelial cell growth factor (PD-ECGF), CD31, CD35 and CD105 were decreased, indicating anti-angiogenesis. The nsPEFs activate multiple melanoma therapeutic targets, which is consistent with successes of nsPEF applications for tumor treatment in vivo as a new cancer therapeutic modality.

1755-148X/asset/olbannercenter.gif?v=1&s=72f30e3842b97b67d7bc25d75c3ceea43fce9409)
